Novavax
Vaccine company
Based in MD
🤖
AI Overview
With $260K in lobbying spend across 10 quarterly filings, Novavax is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2022.
$260K
Total Spend
3
Years Active
1
Firms Hired
6
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $60K |
| 2021 | $160K |
| 2022 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Novavax disclosed contacting in their lobbying filings.
Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATEExecutive Office of the President (EOP)Office of the Vice President of the United States
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.